Released February 9th, 2021
Michael Dempsey - Investing in Bleeding Edge Technology
Michael is a Partner at Compound, a seed-stage venture fund based in New York. We cover the rise of virtual influencers, how to identify key inflection points in the evolution of new technologies, and why computational biology might be the single best technology bet right now.
Professional Investors
Venture Capital
Listen now on
You must be logged in to view this content. Don't have an account? Register here. (It's free)